Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 22024-12-06NCT02315716

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Amgen180
University College, London222

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Barnet HospitalLondonUnited Kingdom2
Birmingham Heartlands HospitalBirminghamUnited Kingdom19
Bradford Royal InfirmaryBradfordUnited Kingdom5
Churchill HospitalOxfordUnited Kingdom43
City Hospital SunderlandSunderlandUnited Kingdom1
Guy's HospitalLondonUnited Kingdom44
Kent and Canterbury HospitalCanterburyUnited Kingdom1
King's College HospitalLondonUnited Kingdom57
Maidstone and Tunbridge WellsMaidstoneUnited Kingdom1
Medway NHS Foundation TrustGillinghamUnited Kingdom3
NHS LanarkshireBothwellUnited Kingdom2
Queen's HospitalRomfordUnited Kingdom3
Royal Hallamshire HospitalSheffieldUnited Kingdom1
Royal Stoke University HospitalStokeUnited Kingdom1
Royal United HospitalBathUnited Kingdom12
St Bartholomew's HospitalLondonUnited Kingdom40
St George's HospitalLondonUnited Kingdom15
St James' HospitalLeedsUnited Kingdom1
University College London HospitalLondonUnited Kingdom32
University Hospital of WalesCardiffUnited Kingdom31